Inokuchi, K <br/><br/>
Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.  [electronic resource] 

 -  Leukemia & lymphoma  May 1998 
 - 553-61 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199809050915  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Core Binding Factor Alpha 2 Subunit<br/>DNA, Neoplasm--analysis<br/>Disease-Free Survival<br/>Flow Cytometry<br/>Humans<br/>Immunophenotyping<br/>Killer Cells, Natural--pathology<br/>Leukemia, Myeloid, Acute--genetics<br/>Leukemia, Promyelocytic, Acute--genetics<br/>Neoplasm Proteins--analysis<br/>Neoplasm, Residual<br/>Oncogene Proteins, Fusion--analysis<br/>Polymerase Chain Reaction<br/>Predictive Value of Tests<br/>RUNX1 Translocation Partner 1 Protein<br/>Recombinant Fusion Proteins--analysis<br/>Remission Induction<br/>T-Lymphocyte Subsets--pathology<br/>Time Factors<br/>Transcription Factors--analysis